πŸ‡ΊπŸ‡Έ FDA
Patent

US 7582284

Particulate materials

granted A61KA61K9/0043A61K9/008

Quick answer

US patent 7582284 (Particulate materials) held by Nektar Therapeutics expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
62
CPC classes
A61K, A61K9/0043, A61K9/008, A61K9/1688